Alaunos Therapeutics, Inc.

Alaunos Therapeutics, Inc.verified

TCRT

Price:

$3.59

Market Cap:

$8.01M

Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers; hunTR, a human neoantigen T-cell receptor platform; and mbIL-15 to treat solid tumors. Alaunos Therapeutics, Inc. has a license agreement with PGEN Therapeutics, Inc.; research and development agreement with The University of Texas MD Anderson Cancer Center; and a patent license agreement, and research and developm...[Read more]

Industry

Biotechnology

IPO Date

2005-08-24

Stock Exchange

NASDAQ

Ticker

TCRT

The Current Ratio as of December 2025 (TTM) for Alaunos Therapeutics, Inc. (TCRT) is 2.92

According to Alaunos Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.92. This represents a change of 2.46% compared to the average of 2.85 of the last 4 quarters.

Alaunos Therapeutics, Inc. (TCRT) Historical Current Ratio (quarterly & annually)

How has TCRT Current Ratio performed in the past?

The mean historical Current Ratio of Alaunos Therapeutics, Inc. over the last ten years is 5.92. The current 2.92 Current Ratio has changed 4.83% with respect to the historical average. Over the past ten years (40 quarters), TCRT's Current Ratio was at its highest in in the March 2020 quarter at 11.56. The Current Ratio was at its lowest in in the September 2018 quarter at 0.78.

Quarterly (TTM)
Annual

Average

5.92

Median

5.77

Minimum

2.23

Maximum

8.89

Alaunos Therapeutics, Inc. (TCRT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Alaunos Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 106.66%

Maximum Annual Current Ratio = 8.89

Minimum Annual Increase = -54.70%

Minimum Annual Current Ratio = 2.23

Quarterly (TTM)
Annual
YearCurrent RatioChange
20243.98-5.73%
20234.2289.71%
20222.23-54.70%
20214.91-30.88%
20207.11-15.58%
20198.42-5.24%
20188.89104.19%
20174.35-34.39%
20166.63-21.17%
20158.42106.66%

Alaunos Therapeutics, Inc. (TCRT) Average Current Ratio

How has TCRT Current Ratio performed in the past?

The current Current Ratio of Alaunos Therapeutics, Inc. (TCRT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

3.48

5-year avg

4.49

10-year avg

5.92

Alaunos Therapeutics, Inc. (TCRT) Current Ratio vs. Peers

How is TCRT’s Current Ratio compared to its peers?

Alaunos Therapeutics, Inc.’s Current Ratio is less than Radiopharm Theranostics Limited (3.37), less than Cyclerion Therapeutics, Inc. (5.78), less than Pasithea Therapeutics Corp. (4.02), less than VYNE Therapeutics Inc. (8.87), greater than Quoin Pharmaceuticals, Ltd. (1.95), greater than Addex Therapeutics Ltd (2.31), less than Polyrizon Ltd. (44.04), greater than AIM ImmunoTech Inc. (0.64), greater than XTL Biopharmaceuticals Ltd. (0.61), greater than Impact BioMedical Inc. (0.06),

Build a custom stock screener for Alaunos Therapeutics, Inc. (TCRT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alaunos Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alaunos Therapeutics, Inc. (TCRT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alaunos Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Alaunos Therapeutics, Inc.'s Current Ratio?

How is the Current Ratio calculated for Alaunos Therapeutics, Inc. (TCRT)?

What is the highest Current Ratio for Alaunos Therapeutics, Inc. (TCRT)?

What is the 3-year average Current Ratio for Alaunos Therapeutics, Inc. (TCRT)?

What is the 5-year average Current Ratio for Alaunos Therapeutics, Inc. (TCRT)?

How does the current Current Ratio for Alaunos Therapeutics, Inc. (TCRT) compare to its historical average?